Condition: Complex Regional Pain Syndrome Type I · Sponsor: Ambros Therapeutics, Inc.
Phase 3 Trial of AMBTX-01 (neridronate) for Complex Regional Pain Syndrome Type 1
This description comes directly from the study's public registry record.
SVP, Clinical Operations · +1 949-785-4954 · clinicaltrials@ambrostx.com
Ambros Therapeutics, Inc
Always discuss trial participation with your own doctor first.
| Ambros Clinical Trial Site | Phoenix, Arizona, United States | Recruiting |
| Ambros Clinical Trial Site | Tucson, Arizona, United States | Recruiting |
| Ambros Clinical Trial Site | Napa, California, United States | Recruiting |
| Ambros Clinical Trial Site | Pasadena, California, United States | Recruiting |
| Ambros Clinical Trial Site | Tustin, California, United States | Recruiting |
| Ambros Clinical Trial Site | Washington D.C., District of Columbia, United States | Recruiting |
| Ambros Clinical Trial Site | Brandon, Florida, United States | Recruiting |
| Ambros Clinical Trial Site | Daytona Beach, Florida, United States | Recruiting |
| Ambros Clinical Trial Site | Pembroke Pines, Florida, United States | Recruiting |
| Ambros Clinical Trial Site | Lawrenceville, Georgia, United States | Recruiting |
| Ambros Clinical Trial Site | Newnan, Georgia, United States | Recruiting |
| Ambros Clinical Trial Site | Chicago, Illinois, United States | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07210515